Highlights
- 1Nature genetics · 2022
- 2Cell genomics · 2025
Publications
Funding
Active
7 grants- PIPCT 251955-02Elucidating the Molecular Drivers of Hodgkin versus Non-Hodgkin LymphomasPew Charitable Trusts · 2025–2029
- PIALSF 261219-01Elucidating Primary CNS Germ Cell Tumors via Single Cell and Spatial Multi-omicsAlex's Lemonade Stand Foundation · 2026–2028
- PISA 241034-01PIRC Mouse Ropeg Sponsored Research AgreementPharmaEssentia · 2024–2027Contract
- PIBWF 1020900Defining the impact of somatic mutations on human hematopoiesis via single-cell multi-omicsBurroughs Wellcome Fund · 2020–2027
- Co-IPSF 2519092-01Unleashing Peritoneal-Resident Memory T cells to Eliminate Ovarian CancerPershing Square Foundation · 2025–2027
- PIR01HL167139-04Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem CellsNational Heart, Lung, and Blood Institute · 2023–2027· 2 renewals
- PII17-0110Modulating Inflammation to Eradicate Clonal Stem CellsStarr Cancer Consortium · 2024–2026
Completed grants (4)
- PIDP5OD029619-04S1Defining malignant hematopoiesis via single-cell multi-omics - DP5 diversity supplement applicationOffice of the Director, NIH · 2020–2025· 2 renewals
- PIK08HL151960-01Integrating genetic, epigenetic, and microenvironmental determinants of myeloproliferative neoplasms via single-cell multi-omicsNational Heart, Lung, and Blood Institute · 2020–2025Career
- KPSCC I15-0016Defining the evolution and tumor microenvironment interactions of classic Hodgkin lymphoma through single-cell multi-omics and genetically engineered mouse modelsStarr Cancer Consortium · 2022–2024
- Co-II15-0026Early intervention for the prevention of blood cancer development.Starr Cancer Consortium · 2022–2023
Honors & distinctions
- Career Award · Burroughs Wellcome Fund · 2020
Clinical research
Active
1 study- PIDefining normal and malignant blood development via single-cell multi-omicsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2021)
News mentions
- Weill Cornell Launches Physician-Scientist Program to Support Early to Mid-Career FacultyNovember 4, 2026
The initiative provides physician-scientists with extended periods of dedicated time to pursue research that is financially compartmentalized from their clinical responsibilities.
- How Interferon Changes Cancerous Blood Stem CellsSeptember 15, 2026
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators.
- Dr. Anna Nam Receives Hartwell Foundation Individual Biomedical Research AwardMay 28, 2026
Dr. Anna Nam has received a 2025 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
- Cancer Progression Illuminated by New Multi-Omics ToolOctober 10, 2025
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells.
- Two Weill Cornell Medicine Scientists Selected for 2025 Pew AwardsAugust 14, 2025
Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecelia Lira have been chosen to join the 2025 class of Pew scholars and fellows.
Show 5 more mentions
- New Starr Cancer Consortium Grants Awarded to Weill Cornell Medicine ResearchersOctober 30, 2024
Three teams led by Weill Cornell Medicine scientists have received awards from the Starr Cancer Consortium in its 17th and final annual grant competition
- Study Illuminates Precancerous "Clonal Outgrowth" in Blood CellsSeptember 22, 2022
A common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may promote these diseases by altering the stem cells’ programming of gene activity and the mix of blood cells they produce.
- New Collaborations Win Funding from Starr Cancer ConsortiumMarch 10, 2022
Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.
- Record Number of Weill Cornell Faculty Win ASCI Young Physician-Scientist AwardsMay 27, 2021
Eight Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation (ASCI), the most awarded to any institution this year.
- Dr. Anna S. Nam Honored with Two Prestigious Awards for Early Career Physician-ScientistsOctober 6, 2020
Dr. Anna S. Nam, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has received a 2020 Early Independence Award from the National Institutes of Health’s (NIH) High Risk, High Reward Research program and a 2020 Burroughs Wellcome Fund Career Award for Medical Scientists.
Media highlights
- Study Maps How Interferon Changes Mutant Blood Stem CellsFingerLakes1.com · September 21, 2026
Mentoring
- DIDanielle IsakovMD-PhD WGS Cell & Developmental Biology (MD-PhD)
- MNMathis NozaisPostdoc mentee · 2025–2026